Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer's and Type 2 Diabetes Diseases

被引:45
作者
Ben Hmidene, Asma [1 ]
Hanaki, Mizuho [2 ]
Murakami, Kazuma [2 ]
Irie, Kazuhiro [2 ]
Isoda, Hiroko [3 ,4 ]
Shigemori, Hideyuki [4 ]
机构
[1] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan
[2] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan
[3] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan
[4] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan
基金
日本学术振兴会;
关键词
amyloid aggregation; glucuronosylated flavonoid; Tamarix gallica; Alzheimer's disease; type; 2; diabetes; BETA AGGREGATION; PROTEIN; CONSTITUENTS;
D O I
10.1248/bpb.b16-00801
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The prevention of amyloid aggregation is promising for the treatment of age-related diseases such as Alzheimer's (AD) and type 2 diabetes (T2D). Ten antioxidant flavonoids isolated from the medicinal halophyte Tamarix gallica were tested for their amyloid aggregation inhibition potential. Glucuronosylated flavonoids show relatively strong inhibitory activity of Amyloid beta (A beta) and human islet amyloid polypeptide (hIAPP) aggregation compared to their aglycone analogs. Structure-activity relationship of the flavonoids suggests that the catechol moiety is important for amyloid aggregation inhibition, while the methylation of the carboxyl group in the glucuronide moiety and of the hydroxyl group in the aglycone flavonoids decreased it.
引用
收藏
页码:238 / 241
页数:4
相关论文
共 25 条
[1]
Type 2 diabetes mellitus and Alzheimer's disease [J].
Barbagallo, Mario ;
Dominguez, Ligia J. .
WORLD JOURNAL OF DIABETES, 2014, 5 (06) :889-893
[2]
Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease [J].
Blazquez, Enrique ;
Velazquez, Esther ;
Hurtado-Carneiro, Veronica ;
Miguel Ruiz-Albusac, Juan .
FRONTIERS IN ENDOCRINOLOGY, 2014, 5
[3]
PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS [J].
COOPER, GJS ;
WILLIS, AC ;
CLARK, A ;
TURNER, RC ;
SIM, RB ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8628-8632
[4]
Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation [J].
Green, JD ;
Goldsbury, C ;
Kistler, J ;
Cooper, GJS ;
Aebi, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12206-12212
[5]
TARGETING OF CELL-SURFACE BETA-AMYLOID PRECURSOR PROTEIN TO LYSOSOMES - ALTERNATIVE PROCESSING INTO AMYLOID-BEARING FRAGMENTS [J].
HAASS, C ;
KOO, EH ;
MELLON, A ;
HUNG, AY ;
SELKOE, DJ .
NATURE, 1992, 357 (6378) :500-503
[6]
Increased risk of type 2 diabetes in Alzheimer disease [J].
Janson, J ;
Laedtke, T ;
Parisi, JE ;
O'Brien, P ;
Petersen, RC ;
Butler, PC .
DIABETES, 2004, 53 (02) :474-481
[7]
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis [J].
Kayed, R ;
Head, E ;
Thompson, JL ;
McIntire, TM ;
Milton, SC ;
Cotman, CW ;
Glabe, CG .
SCIENCE, 2003, 300 (5618) :486-489
[8]
Antioxidant and antimicrobial activities of the edible medicinal halophyte Tamarix gallica L. and related polyphenolic constituents [J].
Ksouri, Riadh ;
Falleh, Hanen ;
Megdiche, Wided ;
Trabelsi, Najla ;
Mhamdi, Baya ;
Chaieb, Kamel ;
Bakrouf, Amina ;
Magne, Christian ;
Abdelly, Chedly .
FOOD AND CHEMICAL TOXICOLOGY, 2009, 47 (08) :2083-2091
[9]
Inhibition of Amyloid β Aggregation by Acteoside, a Phenylethanoid Glycoside [J].
Kurisu, Manami ;
Miyamae, Yusaku ;
Murakami, Kazuma ;
Han, Junkyu ;
Isoda, Hiroko ;
Irie, Kazuhiro ;
Shigemori, Hideyuki .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2013, 77 (06) :1329-1332
[10]
Identification of natural epimeric flavanone glycosides by NMR spectroscopy [J].
Maltese, Federica ;
Erkelens, Cornelis ;
van der Kooy, Frank ;
Choi, Young Hae ;
Verpoorte, Robert .
FOOD CHEMISTRY, 2009, 116 (02) :575-579